22q Deletion Syndrome | CHOP Research Institute

22q Deletion Syndrome

The Emanuel Lab investigates diseases caused by abnormalities of human chromosome 22.

Published on
Oct 29, 2020
Chemogenetic technology is making it more possible to identify abnormal circuitry, correct it, and change the relevant behaviors.

Dr. Mascarenhas is director of the Nutrition Support Service, section chief of nutrition in the Division of Gastroenterology and Nutrition, medical director of the Clinical Nutrition Department, and director of the Integrative Health Program. Her research interests involve 22q deletion syndrome, cystic fibrosis, nutrition, and integrative medicine.

mascarenhas [at] chop.edu